125 related articles for article (PubMed ID: 8120867)
41. Potential virtual lead identification in the discovery of renin inhibitors: application of ligand and structure-based pharmacophore modeling approaches.
Thangapandian S; John S; Sakkiah S; Lee KW
Eur J Med Chem; 2011 Jun; 46(6):2469-76. PubMed ID: 21497958
[TBL] [Abstract][Full Text] [Related]
42. Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors.
Weber AE; Halgren TA; Doyle JJ; Lynch RJ; Siegl PK; Parsons WH; Greenlee WJ; Patchett AA
J Med Chem; 1991 Sep; 34(9):2692-701. PubMed ID: 1895289
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
Maibaum J; Rich DH
J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
[TBL] [Abstract][Full Text] [Related]
44. alpha-Hydroxy phosphinyl-based inhibitors of human renin.
Patel DV; Rielly-Gauvin K; Ryono DE; Free CA; Rogers WL; Smith SA; DeForrest JM; Oehl RS; Petrillo EW
J Med Chem; 1995 Oct; 38(22):4557-69. PubMed ID: 7473584
[TBL] [Abstract][Full Text] [Related]
45. New renin inhibitors containing phenylalanylhistidyl-gamma-amino acid derivatives in P3 - P1' position.
Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
Acta Pol Pharm; 2014; 71(1):59-69. PubMed ID: 24779195
[TBL] [Abstract][Full Text] [Related]
46. Substrate specificity of porcine renin: P1', P1, and P3 residues of renin substrates are crucial for activity.
Wang W; Liang TC
Biochemistry; 1994 Dec; 33(48):14636-41. PubMed ID: 7981226
[TBL] [Abstract][Full Text] [Related]
47. Synthesis of human renin inhibitory peptides, angiotensinogen transition-state analogs containing a retro-inverso amide bond.
Harada H; Iizuka K; Kamijo T; Akahane K; Yamamoto R; Nakano Y; Tsubaki A; Kubota T; Shimaoka I; Umeyama H
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3042-7. PubMed ID: 2085885
[TBL] [Abstract][Full Text] [Related]
48. The human renin infused rat: use as an in vivo model for the biological evaluation of human renin inhibitors.
Bolger G; Vigeant JC; Liard F; Simoneau B; Thibeault D; Pilote L; Lamarre D; Jung G; Anderson P; Jaramillo J
Can J Physiol Pharmacol; 1999 Nov; 77(11):886-95. PubMed ID: 10593662
[TBL] [Abstract][Full Text] [Related]
49. 1,2,4-Triazolo[4,3-a]pyrazine derivatives with human renin inhibitory activity. 1. Synthesis and biological properties of alkyl alcohol and statine derivatives.
Roberts DA; Bradbury RH; Brown D; Faull A; Griffiths D; Major JS; Oldham AA; Pearce RJ; Ratcliffe AH; Revill J
J Med Chem; 1990 Sep; 33(9):2326-34. PubMed ID: 2118183
[TBL] [Abstract][Full Text] [Related]
50. Design and synthesis of renin inhibitors: incorporation of transition-state isostere side chains that span from the S1 to the S3 binding pockets and examination of P3-modified renin inhibitors.
Plummer MS; Shahripour A; Kaltenbronn JS; Lunney EA; Steinbaugh BA; Hamby JM; Hamilton HW; Sawyer TK; Humblet C; Doherty AM
J Med Chem; 1995 Jul; 38(15):2893-905. PubMed ID: 7636850
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a potent inhibitor of subprimate and primate renins.
Wood JM; Mah SC; Baum HP; de Gasparo M; Cumin F; Rüeger H; Nussberger J
J Pharmacol Exp Ther; 1990 May; 253(2):513-7. PubMed ID: 2110974
[TBL] [Abstract][Full Text] [Related]
52. Effects of the renin inhibitor N-[N-(3-(4-amino-1-piperidinyl-carbonyl)-2(R)-benzylpropionyl)-L- histid inyl] -(2S,3R,4S)-1-cyclohexyl-3,4-dihydroxy-6(2-pyridyl)-hexane-2-amide acetate in anesthetized rhesus monkeys.
Linz W; Heitsch H; Henning R; Jung W; Kleemann HW; Nickel WU; Ruppert D; Urbach H; Wagner A; Schölkens BA
Arzneimittelforschung; 1994 Jul; 44(7):815-20. PubMed ID: 7945514
[TBL] [Abstract][Full Text] [Related]
53. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
54. Selective phosphinate transition-state analogue inhibitors of the protease of human immunodeficiency virus.
Grobelny D; Wondrak EM; Galardy RE; Oroszlan S
Biochem Biophys Res Commun; 1990 Jun; 169(3):1111-6. PubMed ID: 2114105
[TBL] [Abstract][Full Text] [Related]
55. Renin inhibitory effect of 2-[4-(4'-chlorophenoxy)phenoxyacetylamino]-ethylphosphorylethanolamine (PE-104) in vitro and in vivo.
Hosoki K; Miyazaki M; Yamamoto K
J Pharmacol Exp Ther; 1977 Nov; 203(2):485-92. PubMed ID: 909077
[TBL] [Abstract][Full Text] [Related]
56. Inhibitors of human renin with C-termini derived from amides and esters of alpha-mercaptoalkanoic acids.
Ashton WT; Cantone CL; Tolman RL; Greenlee WJ; Lynch RJ; Schorn TW; Strouse JF; Siegl PK
J Med Chem; 1992 Jul; 35(15):2772-81. PubMed ID: 1495010
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological study of SR 47436, a non-peptide angiotensin II AT1-receptor antagonist, in conscious monkeys.
Lacour C; Roccon A; Cazaubon C; Segondy D; Nisato D
J Hypertens; 1993 Nov; 11(11):1187-94. PubMed ID: 8301099
[TBL] [Abstract][Full Text] [Related]
58. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
[TBL] [Abstract][Full Text] [Related]
59. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
DeForrest JM; Waldron TL; Oehl RS; Scalese RJ; Free CA; Weller HN; Ryono DE
J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
[TBL] [Abstract][Full Text] [Related]
60. Optimization and in vivo evaluations of a series of small, potent, and specific renin inhibitors containing a novel Leu-Val replacement.
Dellaria JF; Maki RG; Bopp BA; Cohen J; Kleinert HD; Luly JR; Merits I; Plattner JJ; Stein HH
J Med Chem; 1987 Nov; 30(11):2137-44. PubMed ID: 3118024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
